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Introduction
Sarcoptes scabiei var. canis infest both dog and
human where causes sarcoptic mange (Scabies). S.
scabiei var. canis destruct the skin, which result
discomfort and dermatitis, and can be complicated
by secondary bacterial infections leading to mor-
tality (The Center for Food Security and Public
Health, 2012).
Sarcoptes scabiei var. canis are burrowing mites
that live in tunnels into the skin. They complete
their whole life cycle on the host but not surviving
for long periods in the environment. Sarcoptes sca-
biei mites burrow in the stratum corneum of the
skin. Female mites live for 1 to 2 months, construct
the characteristic long serpentine tunnels and de-
posit their eggs as they move through the skin.
Hatched larvae migrate to the surface of the skin.
Molting to the nymphal and adult stages takes
place in short burrows called molting pouches. S.
scabiei is very sensitive to desiccation and can sur-
vive outside the host for up to 2 to 3 weeks (The
Center for Food Security and Public Health, 2012).
It could be diagnosed by applying topical tetra-
cycline, which is retained by the burrows and flu-
oresces under a Woods lamp. They may also be
localized with ink. This disease can be confirmed
by the demonstration of the mites, their eggs or
their feces in a skin scraping under microscope
with 40X magnification lens. 
Canine sarcoptic mange could be treated either
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by topical application of acaricide lotions such as
permethrin, crotamiton and benzyl benzoate or by
systemic acaricide preparations such as oral iver-
mectin, pour on selamectin and doramectin injec-
tion. the systemic acaricides are more preferable
than topical acaricides for treatment of canine sar-
coptic mange because the disadvantages of topical
acaricides that is summarized in its need to adjunct
therapies to improve the penetration of topical aca-
ricides to skin crusts to reach tunnels invading
mites and may cause exposure of vet or owner to
risk of mites infestation. 
Molecular analysis has revealed that Sarcoptes
mites belong to a genus consisting of a single het-
erogeneous species (Zahler et al., 1999). Sarcoptic
mange may be transferable to other species (Arlian
et al., 1984; Folz et al., 1984).This study aimed to
investigate Sarcoptes scabiei var. canis infestation
among different dogs breeds and evaluate three
acaricides for the treatment of infested dogs.
Materials and methods
Three hundred ninety five dogs were examined
clinically for detection of skin lesions and parasito-
logically by skin scraping for detection of Sar-
coptes scabiei var canis at the teaching hospital of
Department of Medicine and Infectious Diseases,
Faculty of Veterinary Medicine, Cairo University.
The infested dogs were classified into three groups
where each group (8 infested dogs) was separately
treated with one of the acaricides. Ivermectin
tablets ((Ivactin®, Delta pharm co., Egypt), Se-
lamectin pour-on ((Revolution®, Pfizer, USA),
Doramectin injection(Dectomax®, Pfizer, USA)
were evaluated as acaricides for treatment of the
infested dogs that were examined weekly post
treatment by clinical and skin scrapings examina-
tions. The clinical improvements and results of skin
scrapings examinations were recorded.
Skin scrapings from the examined dogs were
collected (Alasaad et al., 2009; Fain, 2009; Deger
and Ural, 2013) from the adjunctive sites to healthy
tissues where believed to be most likely to yield
mites and to those of visible suspected lesions. Hair
was clipped thoroughly the affected areas of skin
from the examined dogs were deeply scraped with
scalpel till blood oozing then the collected skin
crusts and tissues were placed in universal bottles
containing 70% ethanol and transported to the lab-
oratory. A portion was removed from the alcohol
and subjected to KOH to recover parasites for mi-
croscopy. The collected mites were identified as
Sarcoptes scabiei var canis on the basis of known
morphological criteria. The data were recorded on
the presence or absence of live mites(larva, nymph
and adult) within skin scrapings. The scrapings
were performed (on days 0, 7, 14, 21 and 28) post-
treatment at those sites. 
Three acaricides were administered twice for
the treatment of Sarcoptes scabiei var canis in-
fested dogs, the first dose was applied at  the be-
ginning of treatment and the second dose was
administered two weeks later. Then they were eval-
uated by clinical improvements and parasitological
examinations.
Ivermectin tablets ((Ivactin®, Delta pharm co.,
Egypt) was administered (Elmogy et al.,1999) in a
dose of 200 micrograms/kg bwt per os.
Selamectin pour-on ((Revolution®, Pfizer, USA)
is topical parasiticide that is formulated to provide
a minimum of 6 mg/kg body weight. It is applied
on the skin of neck of the infested dogs.
Doramectin injection(Dectomax®, Pfizer, USA)  is
1% injectable solution (10mg/ml). Its dose 1
ml/50kg body weight. It is injected subcutaneous.
Results
The results were illustrated in Tables 1 and 2,
and in Figures 1-3.
The recorded clinical signs in the infested dogs
were summarized in alopecia, severe pruritus, skin
crusts, skin thickening, cracks of skin and bleeding
form skin fissures. The owner is usually suffering
from severe itching.
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Fig.1. Two months old German shepherd puppy infested with
Sarcoptes Scabiei mites.
Morphologically, the mature female S. scabiei
were approximately 500 μm long, with fingerprint-
like striations on the cuticle, short  and stubby legs.
The males are similar but smaller (about 275 μm).
The anus is posterior in both sexes, and the first
pair of epimeres is fused in a midventral Y-shape.
Long-stalked, un-jointed pre-tarsal suckers occur
on legs I and II in both sexes and on legs IV in
males. The remaining legs all terminate in long,
hair-like setae. In addition, each tarsus bears at its
tip one or two highly modified setae in the form of
short spurs. Nymphs resemble females but are
smaller and lack an ovipore. Larvae are similar but
smaller still and have only six legs (OIE, 2013).
The prevalence S. scabiei var canis in totally
examined animals was 6.08%.
The highest prevalence was recorded in German
Shepherd dogs (2.27%) while the lowest was in St.
Bernard dogs (0.25%).
The three acaricides have the same successful
treatment rate (100%) at the fourth weeks post
treatment. While it is clear that Doramectin injec-
tion(Dectomax®)can cure 4 (50%) of the treated
dogs at the end of the first week post treatment.
From the economic point of view, Ivermectin
tablets  (Ivactin®) is the cheapest and he is also
easily administered when compared with the other
two acaricides.
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Table 1. Numbers and percentages of Sarcoptes scabiei infested and non infested dogs
Table 2. Evaluation of three acaricides in Sarcoptes scabeii infested dogs
Fig. 2. One year old Griffon dog infested with Sarcoptes Sca-
biei mites.
Fig. 3. Adult Sarcoptes Scabiei mite(X400)
Discussion
Canine scabies is a severely contagious, non-
seasonal and intensely pruritic skin disease caused
by Sarcoptes scabiei var. canis (Deger and Ural,
2013).The life cycle of Sarcoptes scabiei var. canis
required from the development of egg to adult
about 9-13 days (Arlian, 1989; Arlian et al.,1989).
Maturation of the egg takes 3-4 days, following
which the larva hatches from the egg (Wall and
Shearer, 2001). It is also known that survival off
the host is up to 10 days or less, and greatly de-
pendent on moderate conditions (Arlian, 1989; Ar-
lian et al.,1989). 
The most observable clinical signs of canine
sarcoptic mange is pruritus, alopecia, skin encrus-
tation and skin fissures accompanied by bleeding.
These signs could be explained by female Sar-
coptes scabiei var canis mites make deep tunnels
that cause skin damage and release of histamine
and other inflammatory mediators. The skin in-
flammation is usually associated by loss of hair and
formation of skin crusts. The skin is also lost its
elasticity so the fissures were formed and bleed
(Shelly et al., 2010), they mentioned that the pre-
dominant disease manifestations are mediated
through inflammatory and allergic-like reactions to
mite products, leading to intensely pruritic skin le-
sions.
The prevalence of  Sarcoptes scabiei var canis
in totally examined dogs was 6.08% while that was
previously recorded by Mosallanejad et al.(2012)
as  5.56% in Iran, by Gakuya et al. (2012) as 4•7%
in dogs in Kenya, by Xhaxhiu et al. (2009) as  4.4%
in Albania.
The variant prevalences of Sarcoptes scabiei
var canis in the examined different dog breeds
could be explained by the different immune re-
sponses and susceptibility of each dog breed
against that mite as previously reported by Feather
et al. (2010), they mentioned that the disease pre-
dominantly affects young dogs, of all breeds and
both sexes, implicating age-related immunity.
Mode of action of the three systemic acaricides
(ivermectin, selamectin and doramectin) is the
same (Junquera, 2014) because they are from
macrocyclic lactones.
They act as acaricides by (i)blocking the trans-
mission of neuronal signals of mites, which are ei-
ther paralyzed or starved and died. That could be
done by two effects, firstly they act as agonist of
the GABA (gamma-aminobutyric acid) neurotrans-
mitter in nerve cells, and secondly they binds to
glutamate-gated chloride channels in nerve and
muscle cells of mites. (ii) affecting the reproduction
of mites by diminishing ovi-position or inducing
an abnormal oogenesis. They have no ovicidal ac-
tivity on the eggs of mites (Pan et al., 2006) so the
repeated dose is required to kill the hatched larvae
from eggs of mites found at time of treatment.
The systemic acaricides cure the Sarcoptes sca-
biei var canis infested dogs one month post treat-
ment so they are better than topical acaricides
which need 3 months to eliminate Sarcoptes sca-
biei var canis as previously described by Stanneck
et al. (2012), they mentioned that topical midaclo-
prid/flumethrin collar  eliminated Sarcoptes scabiei
within 3 months.
The three acaricides were applied twice and
have the same rate of treatment success (100%) at
end of the fourth week from the beginning of treat-
ment, but they are different in the ease of adminis-
tration and the cost of treatment so we concluded
the ivermectin tablet is more preferable because it
is administered orally and the cheapest.
Conclusion
It could be concluded that Sarcoptes scabiei var
canis is more prevalent in German Shepherd dogs
and ivermectin tablets is the cheapest and easiest
to administer and more preferable to be used for
treatment of Sarcoptes scabiei var canis infested
dogs.
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